Drug
Epitinib
Epitinib: highest development phase Phase 1, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Epitinib NCT02590952 | Phase 1 | Solid Tumor |
| epitinib succinate NCT03231501 | Phase 1 | Glioblastoma |
Latest
No recent events.
Follow Epitinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.